HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Recruiting · NCT07546929 · Registry updated 2026-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-04-23 | NCT07546929 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Housey Healthcare ULC | 1 |
25 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.